ICOS and neoplasm: The underlying mechanism could be that plasmacytoid DCs (pDCs) in the PTC microenvironment induces the transformation of initial CD4+T cells into FoxP3+ICOS+Tregs through the inducible costimulatory ligand (ICOSL)-ICOS pathway hence resulting in Tregs enrichment and tumor escape.